RecruitingNCT06343181
A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast Cancer
Sponsor
European Institute of Oncology
Enrollment
20 participants
Start Date
Oct 3, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Qualitative observational study with the aim to explore medication adherence in a sample of patients with metastatic breast cancer. Patients with metastatic breast cancer receiving or having received oral oncologic therapy, and attending the Division of Medical Senology at the European Institute of Oncology, will be included and enrolled in this research project."
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria4
- Age over 18 years old;
- Diagnosis of metastatic breast cancer;
- Availability of an internet connection and a PC or Tablet (for remote focus groups);
- Signing of the informed consent.
Exclusion Criteria3
- Presence of psychiatric or neurological conditions impairing the ability to comprehend the questions in Focus Groups or to express free consent to participate in the study;
- Presence of medical or oncological conditions other than metastatic breast cancer;
- Refusal to sign the informed consent.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06343181
Related Trials
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
NCT06157892139 locations
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
NCT066493311 location
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
NCT059645044 locations
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT0708576735 locations
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
NCT0342400545 locations